Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Tax Provisions: 2023-2025

Historic Tax Provisions for Axsome Therapeutics (AXSM) over the last 1 years, with Jun 2025 value amounting to -$1.0 million.

  • Axsome Therapeutics' Tax Provisions was N/A to -$1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.0 million, marking a year-over-year change of. This contributed to the annual value of $85,000 for FY2024, which is 91.15% down from last year.
  • Latest data reveals that Axsome Therapeutics reported Tax Provisions of -$1.0 million as of Q2 2025, which was down 1,276.47% from $85,000 recorded in Q4 2024.
  • Axsome Therapeutics' Tax Provisions' 5-year high stood at $2.6 million during Q1 2023, with a 5-year trough of -$1.0 million in Q2 2025.
  • In the last 3 years, Axsome Therapeutics' Tax Provisions had a median value of -$478,500 in 2023 and averaged $4,667.
  • Data for Axsome Therapeutics' Tax Provisions shows a peak YoY spiked of 125.00% (in 2024) over the last 5 years.
  • Axsome Therapeutics' Tax Provisions (Quarterly) stood at -$340,000 in 2023, then surged by 125.00% to $85,000 in 2024, then reached -$1.0 million in 2025.
  • Its Tax Provisions was -$1.0 million in Q2 2025, compared to $85,000 in Q4 2024 and -$340,000 in Q4 2023.